Literature DB >> 3508526

Targeted drug delivery--some pharmacokinetic considerations.

G Levy1.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3508526     DOI： 10.1023/a:1016413523833

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  7 in total

1.  Pharmacokinetic and pharmacodynamic evaluation for tissue-selective inhibition of cholesterol synthesis by pravastatin.

Authors:  T Hatanaka; S Honda; S Sasaki; K Katayama; T Koizumi
Journal:  J Pharmacokinet Biopharm       Date:  1998-06

Review 2.  Liposomal drug delivery. Advantages and limitations from a clinical pharmacokinetic and therapeutic perspective.

Authors:  R M Fielding
Journal:  Clin Pharmacokinet       Date:  1991-09       Impact factor: 6.447

3.  Comparison and critique of two models for regional drug delivery.

Authors:  R A Siegel; R D MacGregor; C A Hunt
Journal:  J Pharmacokinet Biopharm       Date:  1991-06

4.  Application of a linear recirculation model to drug targeting.

Authors:  A V Boddy; L J Aarons
Journal:  J Pharmacokinet Biopharm       Date:  1991-06

5.  Efficiency of drug targeting: steady-state considerations using a three-compartment model.

Authors:  A Boddy; L Aarons; K Petrak
Journal:  Pharm Res       Date:  1989-05       Impact factor: 4.200

6.  Sustained liver targeting and improved antiproliferative effect of doxorubicin liposomes modified with galactosylated lipid and PEG-lipid.

Authors:  Shaoning Wang; Hui Xu; Jinghua Xu; Ying Zhang; Yingchun Liu; Yi-hui Deng; Dawei Chen
Journal:  AAPS PharmSciTech       Date:  2010-05-19       Impact factor: 3.246

Review 7.  Pharmacokinetics of budesonide (Entocort EC) capsules for Crohn's disease.

Authors:  Staffan Edsbäcker; Tommy Andersson
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.